DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
…
0,570$
-1,72%
Echtzeit-Aktienkurs DBV Technologies S.A
Bid:
Ask:
Nachrichten zur DBV Technologies S.A Aktie
DBV Technologies S.A. (DBVT) Q4 2023 Earnings Call Transcript
…
DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript
…
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their…
Form 8-K DBV Technologies S.A. For: Jul 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q DBV Technologies S.A. For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update
Montrouge, France, July 25, 2023...…
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated InformationMontrouge, France, July 10, 2023...…
DBV Technologies to Participate in Upcoming EAACI Congress 2023
Montrouge, France, June 8, 2023...…
DBV Technologies to Participate in Upcoming Investor Conference
Montrouge, France, June 06, 2023...…
Why Shares of DBV Technologies Jumped Thursday
The New England Journal of Medicine reported phase 3 trial details regarding the companys peanut allergy treatment for toddlers....…
Form 8-K DBV Technologies S.A. For: May 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
Montrouge, France, May 10, 2023...…
Form 10-Q DBV Technologies S.A. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies Reports First Quarter 2023 Financial Results
Montrouge, France, May 4, 2023...…
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA
Montrouge, France, April 19, 2023...…
DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
Montrouge, France, April 12, 2023...…
DBV Technologies files for $250M mixed shelf offering
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies Update
Montrouge, France, March 13, 2023...…
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
Montrouge, France, March 7, 2023...…
DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document
Montrouge, France, March 2, 2023...…
Form 10-K DBV Technologies S.A. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies GAAP EPS of -$1.24, revenue of $4.8M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
Montrouge, France, March 2, 2023...…
DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
Montrouge, France, February 27, 2023...…
DBV Technologies to Participate in Upcoming Investor Conference
Montrouge, France, February 10, 2023...…
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated InformationMontrouge, France, January 23, 2023...…